Ethereum is trading just below the $2,000 resistance level, which it has struggled to surpass in recent weeks despite strong inflows into U.S. spot ETFs. Developers proposed EIP-8361 to reduce issuance as staking grows, potentially limiting supply. However, on-chain data shows mixed signals: exchange reserves are falling, indicating accumulation, but the Coinbase Premium is negative, reflecting weak demand from U.S. investors. Analysts warn of a possible short-term pullback to around $1,500 if support at $1,847 fails. The $2,000 level remains a strong resistance that has yet to turn into support, leaving Ethereum's near-term price direction uncertain.
ARCpoint Inc. has been issued a failure-to-file cease trade order by the British Columbia Securities Commission due to missing its July 29, 2026 deadline to file audited annual financial statements and related documents for the year ended March 31, 2...
Tarsus Pharmaceuticals announced it will host a live webcast on August 6, 2026, to report its second quarter financial results and provide a corporate update. The webcast will be available at 5:00 a.m. PT / 8:00 a.m. ET, with a recorded version acces...
Chainlink (LINK) experienced a significant outflow of 1.26 million tokens from centralized exchanges, the largest since June 29, reducing available supply and easing selling pressure. Institutional adoption is rising, highlighted by DTCC's tokenized ...
Kirby McInerney LLP is investigating Myriad Genetics for possible securities fraud following the company's report of an 11% revenue decline in Q2 2026 and a lowered full-year revenue forecast. The company also disclosed an $11 million revenue reducti...
Kirby McInerney LLP is investigating Dr. Reddy's Laboratories for possible securities fraud following the company's Q1 fiscal 2027 earnings report, which revealed an earnings miss and a ₹2.4 billion provision related to out-of-spec semaglutide batche...
